Table 2.
Patient characteristics.
| Number | 186 |
| Average age, year (range) | 50.6 (19–82) |
| Gender | |
| Male | 122 |
| Female | 64 |
| Average inspection days after transplantation | |
| CS | 41.3 (13–100) |
| Average number of biopsy specimens | 4.9 |
| Primary disease | |
| Acute leukemia | 120 |
| Malignant lymphoma | 38 |
| Myelodysplastic syndrome | 16 |
| Chronic myelogenous leukemia | 5 |
| Others | 7 |
| Stem cell source | |
| Cord blood stem cell transplantation | 125 |
| Bone marrow transplantation | 36 |
| Alloperipheral blood stem cell transplantation | 25 |
| Previous treatment | |
| FLU-based regimen | 161 |
| CY/TBI or CY/BU | 25 |
| Preservation of GVHD | |
| FK + MMF | 72 |
| MTX + CyA/FK/MMF | 57 |
| CyA or FK | 57 |
| Extent of endoscopic insertion | |
| Up to the left-side colon | 15 |
| Until the right-side colon | 17 |
| Terminal ileum | 154 |
FLU: fludarabine; CY: cyclophosphamide; TBI: total body irradiation; BU: busulfan; CyA: cyclosporin A; MTX: methotrexate; MMF: mycophenolate mofetil.